期刊文献+

Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention

Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention
下载PDF
导出
摘要 AIM:To assess a relationship between longitudinal changes in liver fat content and biochemical parameters in obese children after 1-year nutritional intervention.METHODS:Forty-six obese children, 21 males and 25females, aged 6-14 years, underwent metabolic measurements, liver ultrasonography(US) and chemicalshift magnetic resonance imaging(MRI) examinations at baseline and after 1-year nutritional intervention. A child was defined obese if her/his body mass index(BMI)was above the age- and sex-adjusted BMI Cole's curve passing through the cut-off of 30 kg/m2 at 18 years.BMI Z scores were calculated and adjusted for age and gender by using the Cole's LMS-method and Italian reference data. Biochemistry included serum alanine aminotransferase(ALT) and aspartate aminotransferase(AST). Abdominal US and chemical-shift MRI were performed according to a randomized sequence.The same radiologist performed US by a GE Logiq 9(General Electric Healthcare Medical Systems, Milwaukee, WI, United States) using a 3.5-MHz convex array transducer. Liver echogenicity was evaluated independently on videotape by 3 radiologists unaware of the child and MRI outcomes, and a consensus was established. Another experienced radiologist, unaware of the child and US data, performed the abdominal chemicalshift MRI with a 1-t system NT-Intera(Philips Medical Systems, Best, The Netherlands) and a phased-array coil. Liver fat fraction(FF) on MRI was judged elevated when greater than 9%. A FF>18% was considered expressing more severe cases of fatty liver according to Fishbein. A nutritional-behavioral intervention was recommended to promote a normocaloric balanced diet and active lifestyle based on the Italian guidelines for treatment of childhood obesity.RESULTS:Compared to baseline, at the end of intervention children showed lower intakes of energy(mean± SD:2549±1238 Kcal vs 1770±622 Kcal, P<0.0001), total fat(90±47 g vs 52± 23g, P<0.0001),carbohydrates(356±174g vs 241±111 g, P=0.001),and protein(99±48g vs 75±23g, P=0.006) intakes. Prevalence of FF≥9% declined from 34.8%to 8.7%(P<0.01), with a mean reduction of 7.8%(95%CI:5.0-10.6). At baseline, FF was associated with liver biochemical parameters(maximum P<0.001). At the end of the intervention association was found with AST(P=0.017). Change of FF was associated with change in AST(P =0.027) and ALT(P=0.024). Rate of increased liver echogenicity declined from 45.6% to21.7%(P<0.0001). Liver echogenicity was associated with ALT at baseline only(P<0.001). An age-and sexadjusted multiple regression analysis showed that FF change was independently associated with change in serum AST(adjusted regression coefficient 0.348, P=0.048).CONCLUSION:The results suggest that in obese children longitudinal changes in liver fat content based on MRI may be associated with change in serum transaminases suggesting novelty in monitoring nonalcoholic fatty liver disease. AIM:To assess a relationship between longitudinal changes in liver fat content and biochemical parameters in obese children after 1-year nutritional intervention.METHODS:Forty-six obese children, 21 males and 25females, aged 6-14 years, underwent metabolic measurements, liver ultrasonography(US) and chemicalshift magnetic resonance imaging(MRI) examinations at baseline and after 1-year nutritional intervention. A child was defined obese if her/his body mass index(BMI)was above the age- and sex-adjusted BMI Cole’s curve passing through the cut-off of 30 kg/m2 at 18 years.BMI Z scores were calculated and adjusted for age and gender by using the Cole’s LMS-method and Italian reference data. Biochemistry included serum alanine aminotransferase(ALT) and aspartate aminotransferase(AST). Abdominal US and chemical-shift MRI were performed according to a randomized sequence.The same radiologist performed US by a GE Logiq 9(General Electric Healthcare Medical Systems, Milwaukee, WI, United States) using a 3.5-MHz convex array transducer. Liver echogenicity was evaluated independently on videotape by 3 radiologists unaware of the child and MRI outcomes, and a consensus was established. Another experienced radiologist, unaware of the child and US data, performed the abdominal chemicalshift MRI with a 1-t system NT-Intera(Philips Medical Systems, Best, The Netherlands) and a phased-array coil. Liver fat fraction(FF) on MRI was judged elevated when greater than 9%. A FF&gt;18% was considered expressing more severe cases of fatty liver according to Fishbein. A nutritional-behavioral intervention was recommended to promote a normocaloric balanced diet and active lifestyle based on the Italian guidelines for treatment of childhood obesity.RESULTS:Compared to baseline, at the end of intervention children showed lower intakes of energy(mean± SD:2549±1238 Kcal vs 1770±622 Kcal, P&lt;0.0001), total fat(90±47 g vs 52± 23g, P&lt;0.0001),carbohydrates(356±174g vs 241±111 g, P=0.001),and protein(99±48g vs 75±23g, P=0.006) intakes. Prevalence of FF≥9% declined from 34.8%to 8.7%(P&lt;0.01), with a mean reduction of 7.8%(95%CI:5.0-10.6). At baseline, FF was associated with liver biochemical parameters(maximum P&lt;0.001). At the end of the intervention association was found with AST(P=0.017). Change of FF was associated with change in AST(P =0.027) and ALT(P=0.024). Rate of increased liver echogenicity declined from 45.6% to21.7%(P&lt;0.0001). Liver echogenicity was associated with ALT at baseline only(P&lt;0.001). An age-and sexadjusted multiple regression analysis showed that FF change was independently associated with change in serum AST(adjusted regression coefficient 0.348, P=0.048).CONCLUSION:The results suggest that in obese children longitudinal changes in liver fat content based on MRI may be associated with change in serum transaminases suggesting novelty in monitoring nonalcoholic fatty liver disease.
出处 《World Journal of Hepatology》 CAS 2013年第9期505-512,共8页 世界肝病学杂志(英文版)(电子版)
关键词 NONALCOHOLIC FATTY liver disease CHILDHOOD obesity Serum TRANSAMINASES Magnetic resonance imaging NUTRITIONAL intervention Nonalcoholic fatty liver disease Childhood obesity Serum transaminases Magnetic resonance imaging Nutritional intervention
  • 相关文献

参考文献15

  • 1Lucia Pacifico,Michele Di Martino,Carlo Catalano,Valeria Panebianco,Mario Bezzi,Caterina Anania,Claudio Chiesa.T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2011,17(25):3012-3019. 被引量:9
  • 2Lucia Pacifico,Eleonora Poggiogalle,Vito Cantisani,Guendalina Menichini,Paolo Ricci,Flavia Ferraro,Claudio Chiesa.Pediatric nonalcoholic fatty liver disease:A clinical and laboratory challenge[J].World Journal of Hepatology,2010,2(7):275-288. 被引量:6
  • 3Kathleen E. Corey,Michelle Lai,Louis G. Gelrud,Joseph Misdraji,Lydia L. Barlow,Hui Zheng,Karin L. Andersson,Michael Thiim,Daniel S. Pratt,Raymond T. Chung.Non–High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis[J]. Clinical Gastroenterology and Hepatology . 2012 (6)
  • 4Angela Shannon,Naim Alkhouri,Christine Carter-Kent,Lidia Monti,Rita Devito,Rocio Lopez,Ariel E. Feldstein,Valerio Nobili.Ultrasonographic Quantitative Estimation of Hepatic Steatosis in Children With NAFLD[J]. Journal of Pediatric Gastroenterology and Nutrition . 2011 (2)
  • 5Carlo Pozzato,Elvira Verduci,Silvia Scaglioni,Giovanni Radaelli,Michela Salvioni,Antonio Rovere,Gianpaolo Cornalba,Enrica Riva,Marcello Giovannini.Liver Fat Change in Obese Children After a 1-year Nutrition-behavior Intervention[J]. Journal of Pediatric Gastroenterology and Nutrition . 2010 (3)
  • 6Jae Sung Ko,Jung Min Yoon,Hye Ran Yang,Jae Kyung Myung,Hye Ryeung Kim,Gyeong Hoon Kang,Jung-Eun Cheon,Jeong Kee Seo.Clinical and Histological Features of Nonalcoholic Fatty Liver Disease in Children[J]. Digestive Diseases and Sciences . 2009 (10)
  • 7Carlo Pozzato,Giovanni Radaelli,Chiara Dall?Asta,Elvira Verduci,Anna Villa,Chiara Villa,Silvia Scaglioni,Enrica Riva,Antonio E Pontiroli,Gianpaolo Cornalba,Marcello Giovannini.MRI in Identifying Hepatic Steatosis in Obese Children and Relation to Ultrasonography and Metabolic Findings[J]. Journal of Pediatric Gastroenterology and Nutrition . 2008 (4)
  • 8Heather M. Patton,Joel E. Lavine,Mark L. Van Natta,Jeffrey B. Schwimmer,David Kleiner,Jean Molleston.Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis[J]. Gastroenterology . 2008 (6)
  • 9Winston Dunn,Jeffrey B. Schwimmer.The obesity epidemic and nonalcoholic fatty liver disease in children[J]. Current Gastroenterology Reports . 2008 (1)
  • 10GiorgioRadetti,WolfgangKleon,JosephStuefer,KlausPittschieler.Non‐alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging[J]. Acta P?diatrica . 2007 (7)

二级参考文献173

  • 1D'Adamo E, Cali AM, Weiss R, Santoro N, Pierpont B, Northrup V, Caprio S. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010; 33: 1817-1822.
  • 2Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pe- diatric nonalcoholic fatty liver disease. Acta Paediatr 2007; 96:542-547.
  • 3Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004; 39:188-196.
  • 4Schwenzer NF, Machann J, Martirosian P, Stefan N, Sch- raml C, Fritsche A, Claussen CD, Schick F. Quantificationof pancreatic lipomatosis and liver steatosis by MRh com- parison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008; 43:330-337.
  • 5Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill R, McCullough AJ. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999; 30:847-850.
  • 6McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ, Benson M, Powell EE. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepato12009; 51: 389-397.
  • 7Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, Suh DJ, Kim KM, Bae MH, Lee JY, Lee SG, Yu ES. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010; 52: 579-585.
  • 8Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatologv 2005; 41:1313-1321.
  • 9Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, Ana- nia C, Ferrara E, Dvisic G, Chiesa C. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008; 63- 423-427.
  • 10Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity world- wide: international survey. BM12000; 320:1240-1243.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部